JNJ-52488332

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNJ-52488332
Drug Alias NameFlt3-Cys828 inhibitor (Janssen/Proteros Proteros biostructures/VIB/University of Geneva)JNJ-52488332
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFms-related tyrosine kinase 3 ligand inhibitors
TargetsFms-related tyrosine kinase 3 ligand
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesGermany +[4] 
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFlanders Institute for Biotechnology VZWProteros Biostructures GmbHUniversity Of Geneva +[4] 
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A